Adaptimmune Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $174k | 882k | 0.20 |
| 2024-12-31 | $494k | 917k | 0.54 |
| 2024-09-30 | $994k | 1.0M | 0.95 |
| 2024-06-30 | $1.0M | 1.0M | 0.97 |
| 2024-03-31 | $1.4M | 915k | 1.58 |
| 2023-12-31 | $736k | 928k | 0.79 |
| 2023-09-30 | $805k | 1.0M | 0.78 |
| 2023-06-30 | $1.2M | 1.3M | 0.93 |
| 2023-03-31 | $1.4M | 1.3M | 1.09 |
| 2022-12-31 | $1.5M | 1.0M | 1.48 |
| 2022-06-30 | $2.5M | 1.5M | 1.71 |
| 2022-03-31 | $2.9M | 1.4M | 2.06 |
| 2021-12-31 | $5.5M | 1.5M | 3.72 |
| 2021-03-31 | $0 | 1.7M | 0.00 |
| 2020-12-31 | $5.5M | 1.0M | 5.39 |
| 2020-09-30 | $3.6M | 468k | 7.66 |
| 2020-06-30 | $5.0M | 500k | 10.01 |
| 2020-03-31 | $269k | 97k | 2.78 |
| 2019-12-31 | $91k | 76k | 1.19 |
| 2019-09-30 | $478k | 317k | 1.51 |
| 2019-06-30 | $1.1M | 278k | 3.99 |
| 2019-03-31 | $1.7M | 402k | 4.30 |
| 2018-12-31 | $2.5M | 436k | 5.75 |
| 2018-09-30 | $2.0M | 149k | 13.56 |
| 2018-06-30 | $2.5M | 212k | 11.87 |
| 2018-03-31 | $2.1M | 186k | 11.23 |
| 2017-12-31 | $140k | 21k | 6.68 |
| 2017-06-30 | $27k | 6.1k | 4.43 |
| 2017-03-31 | $113k | 21k | 5.49 |
| 2016-12-31 | $137k | 34k | 4.05 |
| 2016-09-30 | $149k | 21k | 7.07 |